Risk of post ‐operative surgical site infections after vedolizumab vs anti‐tumour necrosis factor therapy: a propensity score matching analysis in inflammatory bowel disease

Alimentary Pharmacology&Therapeutics, EarlyView.

Source: Alimentary Pharmacology and Therapeutics - June 7, 2018 Category: Drugs & Pharmacology Authors: K. T. Park , L. Sceats , M. Dehghan , A. W. Trickey , A. Wren , J. J. Wong , R. Bensen , B. N. Limketkai , K. Keyashian , C. Kin Source Type: research